CareersInvestor RelationsCOVID-19

News from Siemens Healthineers

Philipp Grätzel von Grätz

What’s that knocking?

 2020-11-26

Magnetic resonance imaging (MRI) has been part of routine medical practice for years. The big tubes produce fascinating images. No wonder that MRI is seen as the crowning glory of diagnostics. But how exactly does it work? What’s so special about it? We answer twelve questions to give a better idea.

A vision for change: ophthalmology and access to affordable eye care in India

Blindness was once a major problem for people all over India: Care was difficult to access in the early stages of ophthalmological complications. Listen to Aravind Srinivasan, MD, and Chief Medical Officer at the Aravind Eye Hospital in Chennai discuss with Christoph Zindel about how this has changed, even in times of COVID-19.

CEO Bernd Montag on the inflection point for “digital first” in healthcare

Sharing his thoughts on big ideas for 2021 in his second LinkedIn article, CEO Bernd Montag discusses the inflection point for consistent digitalization in healthcare. The COVID-19 pandemic has moved the healthcare sector rapidly toward a much-needed next step: the expectation of "digital first" in healthcare. 

 

Easing the pressure: Smart finance for healthcare

 2020-11-20

The global pandemic is expected to accelerate digital transformation in healthcare, and smart financing is essential to enable this transition. Research from Siemens Financial Services estimates how smart finance can unlock billions for potential digital healthcare transformation - freeing up ‘frozen’ capital. Subscribe to the series to learn more.
 

Telemedical services are already enriching patients care.

Telemedicine report: Virtual visits to the doctor

 2020-11-20

Monitoring vital signs, collecting or evaluating diagnostic findings, performing follow-ups – digital concepts for patient care are appearing in more and more areas of application. They provide added value, and not just since COVID-19.

* This test has not been reviewed by the FDA.

The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Under development. Not available for sale in the U.S.